Brostallicin, a Novel Anticancer Agent Whose Activity Is Enhanced upon Binding to Glutathione1 (original) (raw)
Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione
Maurizio Dincalci
Cancer Research, 2002
View PDFchevron_right
α-Bromoacryloyl derivative of distamycin A (PNU 151807): a new non-covalent minor groove DNA binder with antineoplastic activity
Maurizio D'Incalci
British Journal of Cancer, 1999
View PDFchevron_right
Phase I and pharmacokinetic study of brostallicin (PNU-166196), a new DNA minor-groove binder, administered intravenously every 3 weeks to adult patients with metastatic cancer
Francesco Fiorentini
Clinical cancer research : an official journal of the American Association for Cancer Research, 2003
View PDFchevron_right
Hybrid molecules based on distamycin A as potential antitumor agents
Abdel Zaid
Arkivoc, 2005
View PDFchevron_right
DNA minor groove binders as potential antitumor and antimicrobial agents
Mojgan Aghazadeh Tabrizi
Medicinal Research Reviews, 2004
View PDFchevron_right
Phase I dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumors
Marco Merlano
Cancer Chemotherapy and Pharmacology, 2010
View PDFchevron_right
The potential for new and resilient anti-cancer drugs based upon minor groove binders for DNA
Colin Suckling
Medical Research Archives, 2021
View PDFchevron_right
Synthesis, DNA-binding properties, and antitumor activity of novel distamycin derivatives [Erratum to document cited in CA110(19):173740j]
Nicola Mongelli
Journal of Medicinal Chemistry, 1989
View PDFchevron_right
DNA Binding Properties of Novel Distamycin Analogs That Lack the Leading Amide Unit at the N-Terminus
Santanu Bhattacharya
Biochemical and Biophysical Research Communications, 2000
View PDFchevron_right
PM01183, a new DNA minor groove covalent binder with potent in vitro and in vivo anti-tumour activity
Federico Gago
British Journal of Pharmacology, 2010
View PDFchevron_right
DNA Minor Groove Binders-Inspired by Nature
DR.ibrahim khalaf
Acta Chimica Slovenica, 2016
View PDFchevron_right
Binding of Two Novel Bisdaunorubicins to DNA Studied by NMR Spectroscopy † , ‡
Howard Robinson
Biochemistry, 1997
View PDFchevron_right
PM01183, a new DNA minor-groove covalent binder with potent in vitro and in vivo antitumour activity: Antineoplastic activity of PM01183
Alberto Domingo
British Journal of Pharmacology, 2010
View PDFchevron_right
Design, synthesis, DNA binding, and biological activity of a series of DNA minor-groove-binding intercalating drugs
Christian BAILLY
Journal of Pharmaceutical Sciences, 1989
View PDFchevron_right
Selective DNA interaction of the novel distamycin derivative FCE 24517
Maurizio Dincalci
Cancer Research, 1991
View PDFchevron_right
Distamycin Analogues without Leading Amide at Their N-Termini − Comparative Binding Properties to AT- and GC-Rich DNA Sequences
Santanu Bhattacharya
European Journal of Organic Chemistry, 2002
View PDFchevron_right
Backbone and benzoyl mustard carrying moiety modifies DNA interactions of distamycin analogues
Paolo Lombardi
Nucleic Acids Research, 1996
View PDFchevron_right
DNA-binding and DNA-cleaving properties of a synthetic model AGAGLU related to the antitumour drugs AMSA and bleomycin
Christian BAILLY
Biochemical and Biophysical Research Communications, 1988
View PDFchevron_right
Synthesis and Characterization of DNA Minor Groove Binding Alkylating Agents
Robert Sobol
Chemical Research in Toxicology
View PDFchevron_right
Specific inhibition of human DNA ligase adenylation by a distamycin derivative possessing antitumor activity
Giovanni Ciarrocchi
Nucleic Acids Research, 1991
View PDFchevron_right
Synthesis of distamycin A polyamides targeting G-quadruplex DNA
Francisco Cuenca, Stephen Neidle
Organic & Biomolecular Chemistry, 2006
View PDFchevron_right
CoMFA study of distamycin analogs binding to the minor-groove of DNA: a unified model for broad-spectrum activity
Santosh Khedkar
Journal of Molecular Modeling, 2007
View PDFchevron_right
Cytotoxic α-bromoacrylic derivatives of distamycin analogues modified at the amidino moiety
Nicola Mongelli
Bioorganic & Medicinal Chemistry Letters, 2000
View PDFchevron_right
Synthesis of Two Distamycin Analogs and Their Binding Mode to d(CGCAAATTTGCG)2 in the 2:1 Solution Complexes as Determined by Two-Dimensional 1H-NMR
M. Conte, Paolo Lombardi
Journal of Medicinal Chemistry, 1995
View PDFchevron_right
Targeting DNA quadruplexes with distamycin A and its derivatives: An ITC and NMR study
Antonio Randazzo
Biochimie, 2008
View PDFchevron_right
Drugs Against Cancer: Stories of Discovery and the Quest for a Cure
kurt kohn
2020
View PDFchevron_right
Synthesis structure DNABSA interaction and in vitro cytotoxic activity.pdf
T Silambarasan
View PDFchevron_right
DNA Binding Characteristics of Mithramycin and Chromomycin Analogues Obtained by Combinatorial Biosynthesis
José Portugal, F. Barceló
Biochemistry, 2010
View PDFchevron_right
Chemistry and biology of DNA-binding small molecules
Santanu Bhattacharya
2012
View PDFchevron_right
The Development of New DNA Alkylating Antitumour Agents Modeled on the Natural Product CC-1065
LEESA SWAN
2018
View PDFchevron_right